So... we ended March with $41.1m in liquidity. We can minus the $6m of Calidus. Down to $35.1m.
We had zero debt, but now debt facility is drawn to $42.8m. With $17.2m still available to be drawn.
Revenue of approx. $55m including the hedges.
So basically they have $54.5m in cash/bullion, $43, in debt, ($17m still undrawn).
Liquidity at the start of the quarter was $100m (minus the $6m, $94m).
Liquidity now $71.5m. Net reduction of either $28.5m or $22.5m without the calidus loss.
Which seems about right in the growth/expansion costs are similar to the March Quarter and they generated perhaps $10m free cash flow.
If Roswell performs as hoped, then... we might even see a cash build in the near term, as a lot of the $132m to be spent won't occur until late in CY24.
It will be interesting to see what the market thinks.
- Forums
- ASX - By Stock
- Ann: Tomingley FY2024 Production Update
So... we ended March with $41.1m in liquidity. We can minus the...
-
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALK (ASX) to my watchlist
(20min delay)
|
|||||
Last
46.8¢ |
Change
0.008(1.63%) |
Mkt cap ! $281.1M |
Open | High | Low | Value | Volume |
46.0¢ | 48.0¢ | 45.0¢ | $288.8K | 615.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 35934 | 46.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.5¢ | 71984 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 37145 | 0.465 |
7 | 46265 | 0.460 |
8 | 73707 | 0.455 |
10 | 83876 | 0.450 |
4 | 33474 | 0.445 |
Price($) | Vol. | No. |
---|---|---|
0.475 | 69660 | 13 |
0.480 | 162248 | 16 |
0.485 | 80096 | 10 |
0.490 | 41235 | 6 |
0.495 | 57659 | 2 |
Last trade - 12.16pm 11/10/2024 (20 minute delay) ? |
Featured News
ALK (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online